AUSTIN DIKIBO: Open Payments
NPI 1568091114 · LANHAM, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,754 in 55 payments from 14 companies in 2025. Trend: 2023 $364 · 2024 $756 · 2025 $1,754
Food & beverage: $1,754
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $588 |
| E.R. Squibb & Sons, L.L.C. | 11 | $263 |
| BIOTRONIK INC. | 6 | $193 |
| Boston Scientific Corporation | 4 | $161 |
| PFIZER INC. | 5 | $102 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 5 | $91 |
| Novartis Pharmaceuticals Corporation | 3 | $64 |
| BridgeBio Pharma, Inc. | 2 | $62 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $50 |
| SCPHARMACEUTICALS INC. | 2 | $48 |
Products named: Wegovy, Ozempic, AMVIA EDGE, ELIQUIS, General - Vascular Intervention, LifeVest, LEQVIO, Attruby.
Industry payments across MD — which companies pay providers there.
